Compare Enzyme (MLN) vs Zilliqa (ZIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Zilliqa — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Zilliqa trades at Rp41.28 (market cap Rp825,02M, Rp68,41M 24h volume). The key difference: Zilliqa is far larger — about 6.2× Enzyme's market cap, and Zilliqa's supply is capped (20,1B / 21B ZIL (96%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Zilliqa for 130 Days on average.
| MLN | ZIL | |
|---|---|---|
Market Cap | Rp134,13M | Rp825,02M |
Volume (24h) | Rp104,56M | Rp68,41M |
Circulating Supply | 3,3M MLN | 20,1B / 21B ZIL (96%) |
Typical Hold Time | 29 Days | 130 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Zilliqa (ZIL) is currently trading at Rp42.489 with a bearish technical signal, as indicated by moving averages, though oscillators are neutral. The token is near its 52-week low, with key support at Rp40 and resistance at Rp43. On-chain metrics show a high circulation rate of 96%, with an average hold time of 130 days. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks involve continued downward pressure, low liquidity, and broader crypto market volatility. Investors should monitor for any network upgrades or increased adoption to shift sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Zilliqa
Zilliqa (ZIL) is a public, permissionless blockchain that is designed to offer high throughput with the ability to complete thousands of transactions per second. It seeks to solve the issue of blockchain scalability and speed by employing sharding as a second-layer scaling solution. The platform is home to many decentralized applications, and as of October 2020, it also allows for staking and yield farming.
Read more on ZIL →
